|
PROPRIETARY RESEARCH DATABASES
|
|
PAD Projected by Diabetes Method
|
PAD by Age & Glucose Status
|
2010-2030
|
|
CLI Projected by Diabetes Method
|
CLI by PAD, Age
& Glucose Status
|
2010-2030
|
|
PAD by Disease Severity
|
IC
CLI
Asymptomatic
|
2010-2030
|
|
PAD Percent Diagnosed & Treated
|
Historic
Projected
|
1997-2008*
2010-2030
|
|
CLI by Rutherford Category
|
Rutherford 4
Rutherford 5
Rutherford 6
|
2010-2030
|
|
CLI Treatment Pathways
|
Revascularization
Amputation
Palliative
|
2010-2030
|
|
CLI Treatment Pathways
by Rutherford Category
|
Revascularization
Amputation
Palliative
|
2010-2030
|
|
IC Treatment Pathways
|
Revascularization
Amputation
Exercise
Drug
None
|
2010-2030
|
|
PAD Interventional Market
|
Endovascular
Surgical Bypass
Amputation
|
1997-2008*
2010-2030
|
|
PAD Interventional Market
by Vascular Territory
|
Aortoiliac
Femoropopliteal
Tibioperoneal
|
1997-2008*
2010-2030
|
|
PAD Analysis of Angioplasty
& Atherectomy
|
Number of Procedures
Dollar value
|
2003-2008
|
|
Hospital Discharges by
Disease Severity
|
IC
CLI
|
1997-2008*
|
|
Hospital Costs (Charges)
by Disease Severity
*Most recent year available
|
IC
CLI
|
1997-2008*
|
|
THE SAGE GROUP Research:
In 2008 approximately 1 million interventional procedures were performed to treat PAD. Almost 70% of these were endovascular; surgery and amputation each accounted for less than 20%.
Interventional Market Analysis Based on Treatment with Angioplasty or Atherectomy
|
